Pulling SEC filings + quote and writing the call…
| Fiscal year | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|
| Operating income | -$141M | -$286M | -$357M | -$273M | -$293M | -$273M | -$250M |
| Net income | -$131M | -$285M | -$356M | -$269M | -$283M | -$267M | -$244M |
| EPS (diluted) | -$26.68 | -$21.92 | -$2.14 | -$1.43 | -$1.46 | -$1.16 | -$0.96 |
| Fiscal year | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|
| Operating cash flow | -$85.5M | -$138M | -$251M | -$290M | -$254M | -$223M | -$144M |
| Capital expenditures | $26.1M | $23.9M | $29.9M | $20.9M | $20.0M | $33.4M | $938K |
| Free cash flow | -$112M | -$162M | -$281M | -$311M | -$274M | -$257M | -$145M |
| Fiscal year | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|
| Cash & equivalents | $81.8M | $125M | $253M | $177M | $134M | $128M | $71.9M |
| Total assets | — | $730M | $1.13B | $823M | $565M | $501M | $417M |
| Total liabilities | — | $299M | $401M | $323M | $278M | $251M | $256M |
| Shareholders' equity | -$143M | -$421M | $729M | $499M | $288M | $251M | $161M |
| Retained earnings | — | -$429M | -$785M | -$1.05B | -$1.34B | -$1.60B | -$1.85B |
| Shares (wtd avg diluted) | — | 13.0M | 166M | 188M | 195M | 231M | 253M |
Every figure is extracted from Sana Biotechnology, Inc.’s annual reports as filed with the SEC (XBRL company facts) — no third-party estimates. Fiscal years are labeled by period end; filers occasionally re-tag concepts, so a sparse cell means the company didn’t report that concept for that year. Free cash flow = operating cash flow − capital expenditures.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.